Literature DB >> 20493254

Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the beta-secretase pathway.

Martina Malnar1, Marko Kosicek, Stefan Mitterreiter, Damir Omerbasic, Stefan F Lichtenthaler, Alison Goate, Silva Hecimovic.   

Abstract

The link between cholesterol and Alzheimer's disease has recently been revealed in Niemann-Pick type C disease. We found that NPC1(-/-) cells show decreased expression of APP at the cell surface and increased processing of APP through the beta-secretase pathway resulting in increased C99, sAPPbeta and intracellular Abeta40 levels. This effect is dependent on increased cholesterol levels, since cholesterol depletion reversed cell surface APP expression and lowered Abeta/C99 levels in NPC1(-)(/)(-) cells to the levels observed in wt cells. Finding that overexpression of C99, a direct gamma-secretase substrate, does not lead to increased intracellular Abeta levels in NPC1(-)(/)(-) cells vs. CHOwt suggests that the effect on intracellular Abeta upon cholesterol accumulation in NPC1(-)(/)(-) cells is not due to increased APP cleavage by gamma-secretase. Our results indicate that cholesterol may modulate APP processing indirectly by modulating APP expression at the cell surface and thus its cleavage by beta-secretase. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493254      PMCID: PMC2903680          DOI: 10.1016/j.bbadis.2010.05.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  41 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells.

Authors:  T Yamazaki; T Y Chang; C Haass; Y Ihara
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

3.  Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.

Authors:  V Puri; R Watanabe; M Dominguez; X Sun; C L Wheatley; D L Marks; R E Pagano
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

4.  Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch.

Authors:  W J Ray; M Yao; J Mumm; E H Schroeter; P Saftig; M Wolfe; D J Selkoe; R Kopan; A M Goate
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

5.  Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.

Authors:  Suzanne Wahrle; Pritam Das; Andrew C Nyborg; Chris McLendon; Mikio Shoji; Takeshi Kawarabayashi; Linda H Younkin; Steven G Younkin; Todd E Golde
Journal:  Neurobiol Dis       Date:  2002-02       Impact factor: 5.996

6.  Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch.

Authors:  M Sastre; H Steiner; K Fuchs; A Capell; G Multhaup; M M Condron; D B Teplow; C Haass
Journal:  EMBO Rep       Date:  2001-08-23       Impact factor: 8.807

7.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

8.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

9.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Authors:  B Wolozin; W Kellman; P Ruosseau; G G Celesia; G Siegel
Journal:  Arch Neurol       Date:  2000-10

10.  Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts.

Authors:  Marko Kosicek; Martina Malnar; Alison Goate; Silva Hecimovic
Journal:  Biochem Biophys Res Commun       Date:  2010-02-06       Impact factor: 3.575

View more
  19 in total

1.  Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's.

Authors:  Ivan A Borbon; Robert P Erickson
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

2.  Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

Authors:  Niklas Mattsson; Henrik Zetterberg; Simona Bianconi; Nicole M Yanjanin; Rao Fu; Jan-Eric Månsson; Forbes D Porter; Kaj Blennow
Journal:  JIMD Rep       Date:  2011-09-28

3.  Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

Authors:  Claire E DelBove; Claire E Strothman; Roman M Lazarenko; Hui Huang; Charles R Sanders; Qi Zhang
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

Review 4.  Clarifying lysosomal storage diseases.

Authors:  Mark L Schultz; Luis Tecedor; Michael Chang; Beverly L Davidson
Journal:  Trends Neurosci       Date:  2011-06-30       Impact factor: 13.837

5.  Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Authors:  Niklas Mattsson; Maria Olsson; Mikael K Gustavsson; Marko Kosicek; Martina Malnar; Jan-Eric Månsson; Maria Blomqvist; Johan Gobom; Ulf Andreasson; Gunnar Brinkmalm; Charles Vite; Silva Hecimovic; Caroline Hastings; Kaj Blennow; Henrik Zetterberg; Erik Portelius
Journal:  Metab Brain Dis       Date:  2012-09-01       Impact factor: 3.584

6.  N-glycome of the Lysosomal Glycocalyx is Altered in Niemann-Pick Type C Disease (NPC) Model Cells.

Authors:  Marko Kosicek; Ivan Gudelj; Anita Horvatic; Tanja Jovic; Frano Vuckovic; Gordan Lauc; Silva Hecimovic
Journal:  Mol Cell Proteomics       Date:  2018-01-24       Impact factor: 5.911

Review 7.  Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches.

Authors:  Anton I Rosenbaum; Frederick R Maxfield
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

8.  The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann-Pick type C proteins.

Authors:  Steve Poirier; Gaétan Mayer; Stephanie R Murphy; William S Garver; Ta Yuan Chang; Peter Schu; Nabil G Seidah
Journal:  Traffic       Date:  2013-02-20       Impact factor: 6.215

Review 9.  Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2018-09-13       Impact factor: 3.240

10.  Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived Neurons.

Authors:  Lena F Burbulla; Jessica M Mc Donald; Clarissa Valdez; Fanding Gao; Eileen H Bigio; Dimitri Krainc
Journal:  Mov Disord       Date:  2021-01-13       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.